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Participants
The present case-control study recruited 151 volunteer (male and female, aged 35-60 years) subjects who originated from the eastern province of Saudi Arabia and attended the out-patient blood collection service provided by the King Fahd University Hospital at Al-Khobar in February-July 2016. The subjects were divided into three groups: (1) "nonobese" (body mass index [BMI] <30 kg/m 2 , n = 65), (2) "moderately obese" (BMI 30-35 kg/m 2 , n = 45), and (3) "severely obese" (BMI ≥35 kg/m 2 , n = 41).
Baseline measurements
Sociodemographic and health data for each subject (including sex, age, exhibition of type II diabetes mellitus and/or hypertension, and cigarette use), were provided through a structured questionnaire. Anthropometric data (including subject weight, height, and waist circumference) were measured using a metric and a vertical weight scale, with bare feet, and only light clothing. Each subject's BMI value was indirectly calculated according to the formula below BMI = Subject's weight (kg)/(subject's height [m]) 2
Blood collection and DNA extraction
Whole blood samples (5 ml) were collected in ethylenediaminetetraacetic acid vacutainer tubes through aseptic venipuncture. Genomic DNA was then extracted from the leukocytes contained in 300 µL of each of these samples using an Illustra blood genomicPrep Mini Spin Kit (GE Healthcare Life Sciences Ltd., UK) according to the manufacturer's instructions.
Genotyping analysis
The presence/absence of the UCP2 45-BP I/D polymorphism was assessed through polymerase chain response using a 2 × master mix (Promega; Wisconsin, USA), 1 µL of extracted template DNA, and 1 µL (0.1 µg) each of forward (5' CAG TGA GGG AAG TGG GAG G 3') and reverse (5' GGG GCA GGA CGA AGA TTC 3') primer. DNA amplification was achieved using a thermal profile comprising initial denaturation for 4 min at 95°C, followed by 35 cycles of denaturation for 30 s at 93°C, primer binding for 30 s at 58°C, and elongation for 30 s at 72°C, and a final extension step of 10 min at 72°C. The resultant products (10 µL) were then separated on a 1% agarose gel and visualized using ethidium bromide (0.5 µL/gel). D and I alleles were identified to be present by the appearance of 412-BP and 457-BP bands, respectively [ Figure 1 ].
Statistical analysis
All statistical analyses were performed using GraphPad Prism 7 software (California, USA). Data from all study groups were presented as either the mean ± standard deviation (SD) or as percentage values. Continuous variables were assessed using an analysis of variance (ANOVA), whereas categorical variables were compared using either a Chi-squared or Fisher's exact test. Potential associations between the UCP2 I/D polymorphisms and obesity were evaluated by calculating the odds ratios (ORs), 95% confidence intervals (CIs), and two-sided Chi-squared test and/or Yates' correction P values to conduct logistic regression analyses. A logistic binary regression was used to adjust all ORs for confounding parameters such as subject age and sex. P < 0.05 was considered to indicate statistical significance.
Results
The demographic characteristics of the study population are summarized in Table 1 . The mean age of the study population was 44.78 ± 10.31 years, and no statistical difference in age was observed among the three study groups (P = 0.1023). The overall male/female ratio, which was 72/79 across the three study groups, was reduced in both the moderately and the severely obese subject groups compared to the nonobese group; however, these differences were not statistically significant (P = 0.1663). The mean (± SD) BMI values for the non, moderately, and severely obese subject groups were 26.18 ± 1.92, 32 ± 1.83, and 39.59 ± 3.48, respectively, and significantly different in the conducted ANOVA test (P ≤ 0.0001).
Type II diabetes mellitus and hypertension were more prevalent in the moderately (affecting 40% and 28.9% of subjects, respectively) and the severely obese (affecting 51.1% and 53.65% of subjects, respectively) groups than in the nonobese group (affecting 29.2% and 18.5% of subjects, respectively). In contrast, the frequency of cigarette use was increased in the nonobese group (27.7%) compared to the moderately (13.3%) and severely obese (12.2%) groups.
The UCP2 45-BP I/D genotypes D/D, I/D, and I/I occurred with a frequency of 58.3%, 36.4%, and 5.3% across the total study population, respectively, whereas the deletion and insertion alleles were detected in 76.4% and 23.6% of study subjects, respectively. The D/D genotype was more highly prevalent in the severely obese group (82.9%) compared to the nonobese (46.2%) and moderately obese (53.3%) groups. The logistic regression analysis showed no significant association between the I/X genotypes (where X represents a nonspecified allele) and the development of moderate obesity (OR = 0.75, 95% CI): 0.35-1.59, P = 0.585); however, a strong inverse association was found between these genotypes and severe obesity (OR = 0.18, 95% CI: 0.07-0.44, P = 0.0004) [ Table 2 ].
dIscussIon
The role of the 45-BP I/D polymorphism in exon 8 of the UCP2 gene in the development of obesity is unclear. Thus, the current study investigated the frequency of this polymorphism in nonobese, moderately obese, and severely obese subjects originating from the eastern province of Saudi Arabia. Although no significant association was found between either the insertion or deletion alleles and moderate obesity [ Table 2 ], or with an "overweight" BMI (25-30 kg/m 2 ) or type II diabetes mellitus (data not shown), a strong association was identified between the D/D genotype and severe obesity in this population. In fact, subjects with this genotype were found to experience a 5-fold greater risk for developing severe obesity than those who harbored at least one insertion allele.
Most previously conducted association studies found no direct link between the UCP2 45-BP I/D polymorphism and either obesity or various related metabolic disorders. [7] [8] [9] [10] [11] [12] Notably, some previous studies showed the insertion allele to be positively associated with obesity, contradictory to the findings of the present study. [13] [14] [15] [16] Nevertheless, various studies have produced results consistent with those presented here, suggesting that the D/D genotype may contribute to the development of obesity and its related metabolic disorders. For instance, the deletion allele has been previously associated with lower resting metabolic and energy expenditure rates in young adults, and thus postulated to contribute to the development of obesity at a later age. [4, 17] Similarly, subjects carrying the insertion allele in a metabolically healthy Greek population were previously shown to exhibit improved weight loss profiles compared to those harboring the D/D genotype. [12] Previous screening of a Tongan population with a known increased the prevalence of obesity revealed the D/D genotype to be highly prevalent (97%). [18] Finally, a recent study in the region adjacent to the population analyzed by the present study reported a significant association between the D/D deletion and metabolic syndrome, for which obesity is a well-known risk factor. [19] In Saudi Arabia, obesity is a common health concern caused by excessive caloric intake and/or low physical activity levels. The reduced metabolic and energy expenditure rates incurred by the D/D genotype likely aggravate the tendency to develop severe obesity in this population. [20] Notably, previous analysis of a western Saudi Arabian population showed the I/D polymorphism to be associated with neither obesity nor type II diabetes mellitus. [21] This discrepancy may reflect the fact that this previous study did not consider moderately and severely obese subjects separately, or alternatively, it may reflect genetic differences incurred by geographical separation of the two populations.
conclusIons
The present study showed the distribution of the UCP2 D/D, D/I, and I/I genotypes in the analyzed eastern Saudi Arabian population to be 58.3%, 36.4%, and 5.3%, respectively. Moreover, the D/D genotype was shown to be strongly associated with severe, but not moderate, obesity. These findings provide valuable insights into the genetic contribution of UCP2 to obesity and related disorders in Saudi Arabia and should be confirmed via additional research with larger and more geographically diverse cohorts.
